Skip to main content
. 2017 Feb 28;15(4):2067–2073. doi: 10.3892/mmr.2017.6256

Table II.

Lymphatic invasion and clinicopathological features of lung squamous cell carcinoma.

Variable No. of patients (%) ly0-1 (%) ly2-3 (%) P-value
Age at surgery (years) 0.910
  <68 53 (51.5) 43 (81.1) 10 (18.9)
  ≥68 50 (48.5) 41 (82.0) 9 (18.0)
Gender 0.230
  Male 97 (94.2) 78 (80.4) 19 (19.6)
  Female 6 (5.8) 6 (100.0) 0 (0.0)
Tumor size (mm) 0.028
  ≤30 39 (37.9) 36 (92.3) 3 (7.7)
  >30 64 (62.1) 48 (75.0) 16 (25.0)
Lymph node metastasis <0.001
  n(−) 70 (68.0) 66 (94.3) 4 (5.7)
  n(+) 33 (32.0) 18 (54.5) 15 (45.5)
Venous invasion 0.001
  v(−) 53 (51.5) 50 (94.3) 3 (5.7)
  v(+) 50 (48.5) 34 (68.0) 16 (32.0)
Histological differentiation 0.047
  Well, moderate 90 (87.4) 76 (84.4) 14 (15.6)
  Poorly 13 (12.6) 8 (61.5) 5 (38.5)
Stromal type 0.298
  Medullary, intermediate 70 (68.0) 59 (84.3) 11 (15.7)
  Scirrhous 33 (32.0) 25 (75.8) 8 (24.2)
Infiltrating pattern 0.142
  INFc(−) 64 (62.1) 55 (85.9) 9 (14.1)
  INFc(+) 39 (37.9) 29 (74.4) 10 (25.6)

n(−)/n(+), lymph node metastasis negative/positive; v(−)/v(+), venous invasion negative/positive; INFc(−)/INFc(+), infiltrating component negative/positive.